Journal - Cardiovascular & Hematological Disorders-Drug Targets

Cardiovascular & Hematological Disorders-Drug Targets

ISSN (Print): 1871-529X
ISSN (Online): 2212-4063

Volume 23, Issues 4, 2023

This journal supports open access

Institutional Members

Topic(s) Covered

3 Topic(s)

View

Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted & Indexed in:

BIOBASE BIOSIS Previews BIOSIS Reviews Reports and Meetings British Library Cabell's Directory/Journalytics Cambridge Scientific Abstracts (CSA)/ProQuest Chemical Abstracts Service/SciFinder CNKI Scholar Dimensions EBSCO EMBASE EMBiology Genamics Journal Seek Google Scholar J-Gate JournalTOCs MediaFinder®-Standard Periodical Directory MEDLINE/PubMed/Index Medicus Norwegian Register OpenAire PubsHub QOAM Scilit Scopus Sherpa Romeo Suweco CZ Ulrich's Periodicals Directory

COPE Compliant

Archived in

Endorsement(s)

"The journal presents the latest developments in various areas of medicinal chemistry. I strongly recommend it to scientists working in the field."

Garry X. Shen
Univ. of Manitoba, Canada